Your session is about to expire
← Back to Search
Adjuvanted vs Standard Vaccine for Flu
Study Summary
This trial is testing whether a more effective influenza vaccine can help protect a community from the virus.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not taken aspirin or products containing salicylate in the last 30 days.You had a severe allergic reaction to the flu vaccine or any of its parts before.I developed Guillain-Barré syndrome within 8 weeks after getting a flu shot.You have a severe allergic reaction to eggs that causes hives, swelling, difficulty breathing, low blood pressure, or shock.My child is healthy and between 6 months to 6 years old.
- Group 1: Adjuvanted Influenza Vaccine
- Group 2: Quadrivalent Influenza Vaccine
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are adults of 20 years and above eligible for enrollment in the experiment?
"This research seeks participants between 6 and 72 months of age."
Is the current clinical trial a pioneering venture?
"At present, 14 distinct trials for Fluad are running in 10 cities from 3 different countries. The first of these ran in 2016 and was conducted by Pharmacyclics LLC., enrolling 42 patients to reach Phase 2 drug approval. Since then, 159 studies have been finalized."
Are there any precedents set by prior experiments involving Fluad?
"Currently, there are 14 different trials assessing Fluad's efficacy and safety. From these studies, one is in Phase 3 of clinical testing. While the majority of investigations are based around Miami, Florida, overall 15 locations have active medical trials examining this medication."
Is Fluad a reliable vaccine for individuals?
"Previous evaluations of Fluad's safety have earned it a score of 3. This is due to its status as an approved medication from Phase 4 trials."
Is it possible for me to become part of this research project?
"This investigation requires 2500 participants in the 6-72 month age range, who have contracted influenza. Specifically, Group A is expected to receive an intervention and must be composed of young children in good health."
Are there opportunities to volunteer for this research endeavor?
"At this point in time, patient recruitment for this trial has closed. It was originally listed on November 1st 2016 and the posting had its last amendment made back in January 6th 2017. Thankfully, there are 124 clinical trials recruiting human participants with influenza as well as 14 studies looking to enrol patients who have Fluad."
How many participants are being recruited to take part in this experiment?
"This trial has now concluded its recruitment phase, with the initial posting date being November 1st 2016 and a final update on January 6th 2017. If you are seeking other studies related to influenza, there are currently 124 human trials and 14 specifically for Fluad actively recruiting participants."
Share this study with friends
Copy Link
Messenger